Banner Image

ACMDBioFab is a hospital-based robotics and biomedical engineering centre, bringing together researchers, clinicians, engineers and industry partners to work alongside each other with a vision to build biological structures.

The centre will embed research into the clinical setting and clinical needs into the research environment to increase and accelerate the rates of clinical breakthroughs such as the BioPen, to replace and ultimately allow regrowth of bone.

Bringing together the group's scientists, clinicians and industry partners as a single cohesive group at the point of care will enable immediacy in problem solving, give greater context to the research programme and allow solutions brought by experts in the field to be finely honed by patients' real-world problems.

Through developing relationships with Australian and international companies, the facility will enable an appreciation of international market trends (historically been hard to obtain in Australia) and improve capabilities to engage with international markets and global supply chains.

Consortium lead St Vincent's Hospital Melbourne
Consortium members

University of Melbourne, University of Wollongong, Swinburne University of Technology, RMIT University, Stryker Australia Pty Ltd

MTPConnect grant $1,100,000
Industry contribution $1,274,864
Project Duration March 2017 - March 2018 (Finished)
Contact Andrew Crettenden, St Vincent's Hospital -

For more information, visit ACMDBioFab.

Twitter: StVincentsMelb  |  LinkedIn: ACMD

Listen to our podcast episode as ACMDBioFab's Centre Manager Cathal O'Connell takes MTPConnect on a virtual tour of the lab.